Monashee Investment Management LLC Exagen Inc. Transaction History

Monashee Investment Management LLC

  • $673 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$12.4 - $17.92 $2.13 Million - $3.09 Million
-172,170 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$13.9 - $22.0 $2.39 Million - $3.79 Million
172,170 New
172,170 $3.01 Million
Q4 2019

Feb 12, 2020
SELL
$12.61 - $28.48 $1.45 Million - $3.28 Million
-115,000 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$14.5 - $17.5 $1.67 Million - $2.01 Million
115,000 New
115,000 $1.78 Million

Others Institutions Holding XGN

# of Institutions
43
Shares Held
6.06M
Call Options Held
1.1K
Put Options Held
6.4K
View Full List

About EXAGEN INC.

XGN Quotes by TradingView
  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $111M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email